Merck
Science-driven cancer medicines
Darmstadt, Germany
Merck refers to two distinct global entities: Merck Group (Germany), a science and technology company in Healthcare, Life Sciences, and Electronics, and Merck & Co., Inc. (USA), a pharmaceutical company focused on cancer treatments, vaccines, and animal health products. Both are prominent in their respective sectors.
How We Help
Core Technology
Developing medicines; providing laboratory reagents, chemicals, and equipment for biotech and pharma; and offering materials and solutions for advanced technologies, including semiconductors, display solutions, and surface solutions, with a focus on innovation and digitalization.
Key Differentiators
Diversified Business Model, Innovation and Technology Leadership (including Materials Intelligence™), Scale and Global Presence, Strategic Acquisitions and Partnerships, Customer Experience and Operational Excellence, Deeply Embedded Sustainability, Long History and Strong Brand Equity
Clinical Focus
Oncology, Neurology & Immunology, Cardiovascular, Metabolism & Endocrinology (CM&E), Fertility, Infectious Diseases and Vaccines
Target Customers
Biotech and pharmaceutical companies, research institutions, electronics manufacturers, hospitals, and clinics.
Product Stage
Mature
Company Info
- Business Model
- B2B
- Founded
- 1668
- Website
- www.merckgroup.com
Categories
Disease Areas
Technologies
Clinical & IP
Clinical Validation
FDA approved subcutaneous KEYTRUDA. FDA accepted RSV prevention BLA (clesrovimab). FDA accepted HIV NDA (doravirine/islatravir). Priority review granted for head/neck cancer. MK-2214 Fast Track Designation (Alzheimers).
MedStartr Index Score
?What do you think of Merck?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.